Últimas subidas - Macular Degeneration - Age Related, Myopic, Choroidal Neovascular Membranes
|
Staphyloma and Atrophy with Vitreoretinal tractionvista 23 vecesOnly eye of patient with Albinism and decreasing vision now 5/200 in this 72 year old man. There is myopic tractional maculopathy. The patient also has albinism by history.Abril 13, 2026
|
|
Staphyloma and Atrophy with Vitreoretinal tractionvista 25 vecesOnly eye of patient with Albinism and decreasing vision now 5/200 in this 72 year old man. There is myopic tractional maculopathy. The patient also has albinism by history.Abril 13, 2026
|
|
Staphyloma and Atrophy with Vitreoretinal tractionvista 27 vecesOnly eye of patient with Albinism and decreasing vision now 5/200 in this 72 year old man. There is myopic tractional maculopathy. The patient also has albinism by history.Abril 13, 2026
|
|
Conversion to Wet AMD after Izervayvista 33 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 39 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 31 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 42 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 34 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 28 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 39 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 33 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 37 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 31 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 32 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 26 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 37 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 32 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 28 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 31 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 30 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 127 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 116 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 122 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 61 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 55 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 57 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 48 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 55 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 50 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 56 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 53 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 63 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 59 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 39 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 42 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 40 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 40 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 42 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 47 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 48 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 33 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 52 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 40 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 32 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 31 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 40 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 57 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 29 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 41 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 39 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 27 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 30 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 40 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 40 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 33 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 33 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 28 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 22 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 32 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 26 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 27 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 37 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 30 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 28 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 37 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 43 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 33 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 35 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 35 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 40 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 39 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 22 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 38 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 36 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 32 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 42 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 50 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 37 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 54 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 43 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 48 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 45 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 47 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 41 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 38 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 52 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 42 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 50 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 45 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 43 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 48 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 43 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 56 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Stable Myopic Tractional Maculopathyvista 48 veces73 year old female with mild vision loss from table myopic tractional maculopathy in the left eyeNoviembre 23, 2025
|
|
Stable Myopic Tractional Maculopathyvista 41 veces73 year old female with mild vision loss from table myopic tractional maculopathy in the left eyeNoviembre 23, 2025
|
|
Stable Myopic Tractional Maculopathyvista 47 veces73 year old female with mild vision loss from table myopic tractional maculopathy in the left eyeNoviembre 23, 2025
|
|
Stable Myopic Tractional Maculopathyvista 41 veces73 year old female with mild vision loss from table myopic tractional maculopathy in the left eyeNoviembre 23, 2025
|
|
Stable Myopic Tractional Maculopathyvista 41 veces73 year old female with mild vision loss from table myopic tractional maculopathy in the left eyeNoviembre 23, 2025
|
|
Stable Myopic Tractional Maculopathyvista 46 veces73 year old female with mild vision loss from table myopic tractional maculopathy in the left eyeNoviembre 23, 2025
|
|
Stable Myopic Tractional Maculopathyvista 36 veces73 year old female with mild vision loss from table myopic tractional maculopathy in the left eyeNoviembre 23, 2025
|
|
| 2694 archivos en 27 página(s) |
1 |
 |
|
|
|
|
|
|
|
|
|
